Free tool
Stocks listed on Nasdaq GS
We cover 44 companies listed on Nasdaq GS. The median market value in the group is $1.71B. Across the group, the median move over the past trading day is −0.01%. 100% of the 42 with a 200-day average trade above it. Price change over the past year runs from −14.1% to +289.3% across the middle 80 percent of the group, with a median of +59.2%.
Other lists in this group
Table
44 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| BZ | Kanzhun Limited | $8.42B | Mid cap | −16.97% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| SSRM | SSR Mining Inc. | $7.90B | Mid cap | +106.56% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| AUGO | Aura Minerals Inc. | $7.49B | Mid cap | +217.63% |
| PAGP | Plains GP Holdings, L.P. | $6.55B | Mid cap | +57.00% |
| EXLS | ExlService Holdings, Inc. | $5.72B | Mid cap | −14.91% |
| MKTX | MarketAxess Holdings Inc. | $5.72B | Mid cap | −12.08% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| LIFE | Ethos Technologies Inc. | $3.75B | Mid cap | +132.11% |
| WIX | Wix.com Ltd. Ordinary Shares | $3.44B | Mid cap | −39.66% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| IOSP | Innospec Inc. | $2.36B | Mid cap | +11.67% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| DSGR | Distribution Solutions Group, Inc. | $1.61B | Small cap | +6.26% |
| SAFT | Safety Insurance Group, Inc. | $1.52B | Small cap | +46.60% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| GO | Grocery Outlet Holding Corp. | $1.21B | Small cap | −34.00% |
| KRT | Karat Packaging Inc. | $981.84M | Small cap | +105.52% |
| STRD | Strategy Inc | $907.06M | Small cap | +1.03% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| MLAB | Mesa Laboratories, Inc. | $712.63M | Small cap | +85.96% |
| HNST | The Honest Company, Inc. | $613.67M | Small cap | +43.72% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | +0.38% |
| BYND | Beyond Meat, Inc. | $245.01M | Small cap | +450.19% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% |
| PROV | Provident Financial Holdings, Inc. | $114.69M | Small cap | +22.46% |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.